The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: A meta-analysis

References

• Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: A review of the epidemiologic literature. Cancer Causes Control 2010;21:967–89.
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353–64.
   PubMed Web of Science ®Google Scholar
• Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006;6:281–91.
   PubMed Web of Science ®Google Scholar
• Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006;126:16–9.
   PubMed Web of Science ®Google Scholar
• Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG. Androgens in preeclampsia. Am J Obstet Gynecol 1999;180:60–3.
   PubMed Web of Science ®Google Scholar
• Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999;10:722–32.
   PubMed Web of Science ®Google Scholar
• Rosing U, Carlstrom K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest 1984;18:199–205.
   PubMed Web of Science ®Google Scholar
• Isouard G. Measurement of serum levels of oestriol and human placental lactogen in the management of pre-eclamptic pregnancies. Med J Aust 1979;2:401–4.
   PubMed Web of Science ®Google Scholar
• Klopper A, Jandial V, Wilson G. Plasma steroid assay in the assessment of foetoplacental function. J Steroid Biochem 1975;6:651–6.
   PubMedGoogle Scholar
• Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?Am J Obstet Gynecol 2000;182:589–94.
   PubMed Web of Science ®Google Scholar
• Warren WB, Gurewitsch ED, Goland RS. Corticotropin- releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension. Am J Obstet Gynecol 1995;172:661–6.
   PubMed Web of Science ®Google Scholar
• Masse J, Forest JC, Moutquin JM, Marcoux S, Brideau NA, Belanger M. A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. Am J Obstet Gynecol 1993;169:501–8.
   PubMed Web of Science ®Google Scholar
• Ranta T, Stenman UH, Unnerus HA, Rossi J, Seppala M. Maternal plasma prolactin levels in preeclampsia. Obstet Gynecol 1980;55:428–30.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992;340:1015–8.
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Kolonel LN, Myers BC, Mi MP. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988;57:437–9.
   PubMed Web of Science ®Google Scholar
• Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983;28:314–8.
   Google Scholar
• Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL, et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007; 165:1007–14.
   PubMed Web of Science ®Google Scholar
• Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004;112:306–11.
   PubMed Web of Science ®Google Scholar
• Richardson BE, Peck JD, Wormuth JK. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: Evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9: 1349–55.
   PubMed Web of Science ®Google Scholar
• Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR, et al. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998;9:641–7.
   PubMed Web of Science ®Google Scholar
• Troisi R, Innes KE, Roberts JM, Hoover RN. Preeclampsia and maternal breast cancer risk by offspring gender: Do elevated androgen concentrations play a role?Br J Cancer 2007;97:688–90.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Perrin MC, Kleinhaus K, et al. Preeclampsia and subsequent risk of cancer: Update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009;200:63e1–5.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: A population-based study. J Natl Cancer Inst 1997;89:71–6.
   PubMed Web of Science ®Google Scholar
• Paltiel O, Friedlander Y, Tiram E, Barchana M, Xue X, Harlap S. Cancer after pre-eclampsia: Follow up of the Jerusalem perinatal study cohort. Br Med J 2004;328:919.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR. The negative association between pre-eclampsia and breast cancer risk may depend on the offspring’s gender. Br J Cancer 2007;96:1436–8.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87:971–3.
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856–69.
   PubMed Web of Science ®Google Scholar
• Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001;93: 1133–40.
   PubMed Web of Science ®Google Scholar
• Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75:1699–703.
   PubMed Web of Science ®Google Scholar
• Thompson WD, Jacobson HI, Negrini B, Janerich DT. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989;81:1571–4.
   PubMed Web of Science ®Google Scholar
• Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D. Sexual dimorphism of blood pressure: Possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991;40:511–5.
   PubMed Web of Science ®Google Scholar
• Gant NF, Hutchinson HT, Siiteri PK, MacDonald PC. Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971;111:555–63.
   PubMed Web of Science ®Google Scholar
• Hahnel ME, Martin JD, Michael CA, Hahnel R. Metabolism of androstenedione by placental microsomes in pregnancy hypertension. Clin Chim Acta 1989;181:103–8.
   PubMed Web of Science ®Google Scholar
• Troisi R, Potischman N, Roberts JM, Ness R, Crombleholme W, Lykins D, et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455–60.
   PubMed Web of Science ®Google Scholar
• Hughes G, Bischof P, Wilson G, Smith R, Klopper A. Tests of fetal wellbeing in the third trimester of pregnancy. Br J Obstet Gynaecol 1980;87:650–6.
   PubMedGoogle Scholar
• Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996;88:816–22.
   PubMed Web of Science ®Google Scholar
• Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999;19:122–7.
   PubMed Web of Science ®Google Scholar
• Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491–4.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ, Vonnegut M, Jacobson HI. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc Natl Acad Sci U S A 1983;80:2733–7.
   PubMed Web of Science ®Google Scholar
• Atamer Y, Erden AC, Demir B, Kocyigit Y, Atamer A. The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 2004;83:425–30.
   PubMed Web of Science ®Google Scholar